307 related articles for article (PubMed ID: 19888524)
1. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
Nowak G
Thromb Haemost; 2009 Nov; 102(5):887-91. PubMed ID: 19888524
[TBL] [Abstract][Full Text] [Related]
2. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
[TBL] [Abstract][Full Text] [Related]
5. Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.
Radaideh SM; Frenkel EP; Dowell JE; Sarode R; Shen YM
Clin Appl Thromb Hemost; 2012; 18(2):215-7. PubMed ID: 22067544
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke.
Kawano H; Toyoda K; Miyata S; Yamamoto H; Okamoto A; Kakutani I; Walenga JM; Naritomi H; Minematsu K
Cerebrovasc Dis; 2008; 26(6):641-9. PubMed ID: 18984950
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
9. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
10. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of heparin-induced thrombocytopenia.
Warkentin TE
Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
[TBL] [Abstract][Full Text] [Related]
12. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
[TBL] [Abstract][Full Text] [Related]
13. HITlights: a career perspective on heparin-induced thrombocytopenia.
Warkentin TE
Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
[TBL] [Abstract][Full Text] [Related]
14. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J
Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181
[TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL
Warkentin TE; Sheppard JI; Linkins LA; Arnold DM; Nazy I
Thromb Res; 2017 May; 153():108-117. PubMed ID: 28391124
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia in myeloproliferative disorders: a rare or under-diagnosed complication?
Spectre G; Kalish Y; Schliamser L; Varon D
Am J Hematol; 2008 May; 83(5):420-3. PubMed ID: 18181201
[TBL] [Abstract][Full Text] [Related]
18. Detection and significance of heparin-platelet factor 4 antibodies.
Francis JL
Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
Mattioli AV
Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
[TBL] [Abstract][Full Text] [Related]
20. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
